Group 1 - The core viewpoint of the articles highlights the rapid development and investment in the health industry in Taizhou, with significant projects being signed, such as the 5 billion yuan R&D center by Xiu Zheng Pharmaceutical Group and the 10.6 billion yuan bio-based materials industrial park [1][2] - The Taizhou government aims to establish a modern industrial system marked by the "Great Health Industry," positioning Taizhou as a key advanced manufacturing base in the Yangtze River Delta [1][2] - The city is actively attracting renowned multinational pharmaceutical companies, enhancing its competitive edge in the biopharmaceutical sector, particularly in vaccines and high-end medical devices [2][3] Group 2 - Taizhou is implementing a dual innovation model that combines offshore R&D in cities like Shanghai with local industrialization, addressing talent acquisition challenges [3] - The city has established offshore innovation centers in Shanghai and Wuxi to facilitate collaboration between local and offshore resources, enhancing its innovation capabilities [3] - The Taizhou Pharmaceutical High-tech Zone aims to achieve a health industry scale of 220 billion yuan by 2025 and 300 billion yuan by 2030, focusing on future industries like cell and gene technology [4]
大项目频频落地 创新力稳步增强 泰州大健康产业持续营造“小阳春”
Xin Hua Ri Bao·2025-04-14 23:49